kol meetingI missed the first part and entered during a disussion of previous unsuccessful treatment regimes.
They turned to the Goblet trial and reviewed the data. Not a great deal that was new was stated. All the participants said that they would be able to recruit patients for a future large scale trial readily, although they would have to allow crossover because no one would want to be on the control arm. They stated that in their view the results seen so far would be considered very solid and a big improvement over SOC if they continue to be demonstrated in a large randomized trial. Finally they noted the complete response is a rare thing, but it was monitored and measured with imaging. They did not expect to see more frequent such responses in a larger tirail
They were all cautious in making statements. It seemed a very serious event.